Skip to main content

Table 3 Overview of the visits and measurements

From: Double blind randomized placebo-controlled trial on the effects of testosterone supplementation in elderly men with moderate to low testosterone levels: design and baseline characteristics [ISRCTN23688581]

Assessment

Information visit and inclusion criteria

Screening and randomization visit

Phone call 6 weeks

Visit 13 weeks

Final visit 26 weeks

 

V1

V2

 

V3

V4

Check in & exclusion criteria

X

X

   

Informed consent

X

    

Medical history (/update)

X

X

X

X

X

Physical examination

 

X

  

X

Vital signs

 

X

 

X

X

Anthropometry

 

X

  

X

Blood sample

X

  

X

X

Glucose

X

   

X

DNA blood sample

X

    

Testosterone

X

   

X

PSA

X

  

X

X

Liver functions

X

  

X

X

Renal functions

X

  

X

X

Hematology

X

  

X

X

Spare blood

X

  

X

X

Rectal Ultrasound

 

X

  

X

Rectal Toucher

 

X

 

X

X

DEXA full body

 

X

  

X

DEXA bone mineral density

 

X

  

X

Ultrasound abdominal fat mass

 

X

  

X

Pulse wave velocity (PWV)

 

X

  

X

Functional mobility

 

X

  

X

Cognition tests

 

X

  

X

Quality of Life (QoL)

 

X

  

X

ADAM/AMS questionnaire

X

   

X

Sexual functioning questionnaire

 

X

  

X

IPSS questionnaire

 

X

X

X

X

Randomization

 

X

   
Back to article page

Trials

ISSN: 1745-6215